Breaking News
How War Propaganda Justifies Conscription Into Unjust Wars
Trump's "Russian sanctions" Have Destroyed the German Automobile Industry
Where are the headlines? 2026 is the 'First Time in 112 Years: No Atlantic Hurricanes By Sept. 2
CNN Staffers Panic over Paramount Merger: 'Bloodbath Coming,' Newsroom Is 'Like a Funera
Top Tech News
BEYOND THE MOON: NASA plans a nuclear-powered fleet to push DEEPER into space
Big Oil Backs Mazama's $135 Million Bet On Superhot Geothermal
Quantum compass takes flight on Northrop's Lumberjack drone
Terrifying AI Behavior Even Its Creators Couldn't Explain
WW3 Near-Miss? AI Hallucinated Nuclear Weapons Components Aboard Chinese Vessel Bound For Iran
Stripe Is Building the Toll Road for the Machine Economy
Toyota Dakar hopeful swaps twin-turbo V6 for hydrogen fuel cells
4-min turbo-inflatable cubic camp castle is now available in the USA
Researchers Used Claude To Hack OpenAI Employee Accounts
Chinese Scientists Develop New Oil Refining Method That Cuts Energy Use by 90%
Finally Confirmed! Vitamin D Nearly Abolishes ICU Risk in COVID-19
The First Randomized Controlled Trial on Vitamin D and COVID-19
The trial was conducted at the Reina Sofi?a University Hospital in Co?rdoba, Spain. The trial included 76 patients with COVID-19 pneumonia. Although this is no longer the standard of care, all patients were treated with hydroxychloroquine and azithromycin and, when needed, a broad-spectrum antibiotic. Admission to the ICU was determined by a multidisciplinary committee consisting of intensive care specialists, pulmonologists, internal medicine specialists, and members of the ethics committee.
The patients were randomly allocated to receive or not receive vitamin D in a 2:1 ratio. This resulted in 50 patients in the vitamin D group and 26 patients in the control group.